Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1991 2
1992 1
1993 1
1994 1
1996 1
1997 1
1998 1
2000 1
2001 1
2002 3
2003 1
2004 2
2005 4
2006 4
2007 4
2008 7
2010 5
2011 3
2012 4
2013 5
2014 5
2015 3
2016 4
2017 8
2018 4
2019 7
2020 8
2021 12
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, Schiavon F, Neumann T, Lopalco G, Novikov P, Baldini C, Lombardi C, Berti A, Alberici F, Folci M, Negrini S, Sinico RA, Quartuccio L, Lunardi C, Parronchi P, Moosig F, Espígol-Frigolé G, Schroeder J, Kernder AL, Monti S, Silvagni E, Crimi C, Cinetto F, Fraticelli P, Roccatello D, Vacca A, Mohammad AJ, Hellmich B, Samson M, Bargagli E, Cohen Tervaert JW, Ribi C, Fiori D, Bello F, Fagni F, Moroni L, Ramirez GA, Nasser M, Marvisi C, Toniati P, Firinu D, Padoan R, Egan A, Seeliger B, Iannone F, Salvarani C, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Bettiol A, et al. Arthritis Rheumatol. 2022 Feb;74(2):295-306. doi: 10.1002/art.41943. Epub 2021 Dec 30. Arthritis Rheumatol. 2022. PMID: 34347947 Free PMC article.
Complete response rates increased to 30.4% and 35.7% at 12 months and 24 months, respectively, and rates were comparable between mepolizumab 100 mg every 4 weeks and 300 mg every 4 weeks. Mepolizumab led to a significant reduction in BVAS score, prednisone dose, and …
Complete response rates increased to 30.4% and 35.7% at 12 months and 24 months, respectively, and rates were comparable between mepolizumab …
Personalized transcranial alternating current stimulation (tACS) and physical therapy to treat motor and cognitive symptoms in Parkinson's disease: A randomized cross-over trial.
Del Felice A, Castiglia L, Formaggio E, Cattelan M, Scarpa B, Manganotti P, Tenconi E, Masiero S. Del Felice A, et al. Neuroimage Clin. 2019;22:101768. doi: 10.1016/j.nicl.2019.101768. Epub 2019 Mar 18. Neuroimage Clin. 2019. PMID: 30921609 Free PMC article. Clinical Trial.
Participants were randomized to tACS or random noise stimulation (RNS), 5 days/week for 2-weeks followed by ad hoc physical therapy. EEG, motor (Unified Parkinson's Disease Rating Scale-motor: UPDRS III), neuropsychological (frontal, executive and memory tests) performance …
Participants were randomized to tACS or random noise stimulation (RNS), 5 days/week for 2-weeks followed by ad hoc physical therapy. …
A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results.
Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, Giugliani R, Guelbert NB, Ikezoe T, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Villarrubia J, Chen Y, Furey S, Thurberg BL, Zaher A, Kumar M. Wasserstein M, et al. Genet Med. 2022 Jul;24(7):1425-1436. doi: 10.1016/j.gim.2022.03.021. Epub 2022 Apr 26. Genet Med. 2022. PMID: 35471153 Free article. Clinical Trial.
METHODS: A phase 2/3, 52 week, international, double-blind, placebo-controlled trial (ASCEND; NCT02004691/EudraCT 2015-000371-26) enrolled 36 adults with ASMD randomized 1:1 to receive olipudase alfa or placebo intravenously every 2 weeks with intrapatient dose escalation …
METHODS: A phase 2/3, 52 week, international, double-blind, placebo-controlled trial (ASCEND; NCT02004691/EudraCT 2015-000371-26) enrolled 3 …
Morphological and morphometric study on human Scarpa ganglion development.
Sanchez Del Rey A, Sánchez Fernández JM, Gutierrez N, Martínez A, Santaolalla Montoya F. Sanchez Del Rey A, et al. Acta Otolaryngol. 2013 Apr;133(4):352-60. doi: 10.3109/00016489.2012.756147. Epub 2013 Jan 28. Acta Otolaryngol. 2013. PMID: 23350596

CONCLUSION: In Scarpa neurons the cell and nuclear area increases and nuclear/cytoplasm ratio decreases with fetal age (p < 0.0001). ...Displacement of a neuron within the internal auditory meatus (IAM) occurs from 9 weeks in the fetus until the neonate. METHODS:

…

CONCLUSION: In Scarpa neurons the cell and nuclear area increases and nuclear/cytoplasm ratio decreases with fetal age (p < 0.0001

…
Three-dimensional anatomy of human Scarpa's ganglion.
Sato H, Sando I, Takahashi H. Sato H, et al. Laryngoscope. 1992 Sep;102(9):1056-63. doi: 10.1288/00005537-199209000-00018. Laryngoscope. 1992. PMID: 1518353
Using a computer-aided three-dimensional reconstruction and measurement method, the authors studied the shape and dimensions of Scarpa's ganglion and interrelations of the ganglion to nearby important anatomical structures in 10 normal human temporal bones obtained …
Using a computer-aided three-dimensional reconstruction and measurement method, the authors studied the shape and dimensions of Scarpa …
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis.
Sablich R, Urbano MT, Scarpa M, Scognamiglio F, Paviotti A, Savarino E. Sablich R, et al. Sci Rep. 2023 Feb 1;13(1):1816. doi: 10.1038/s41598-023-28907-3. Sci Rep. 2023. PMID: 36725872 Free PMC article.
Data were extracted from patients' files and reviewed. The duration of follow-up (FU) was 52 weeks. The primary endpoint was the clinical remission (CR) at the end of FU. ...
Data were extracted from patients' files and reviewed. The duration of follow-up (FU) was 52 weeks. The primary endpoint was the clin …
Influence of preanalytical factors on feline proteinuria.
Giraldi M, Paltrinieri S, Rossi G, Ruggerone B, Zambarbieri J, Ercolani A, Scarpa P. Giraldi M, et al. Vet Clin Pathol. 2021 Sep;50(3):369-375. doi: 10.1111/vcp.12994. Epub 2021 Jul 28. Vet Clin Pathol. 2021. PMID: 34322896
Compared with baseline values, UPC ratios decreased (P < .01) after 8 and 12 weeks at -20. However, all UPC ratios were within the inter-assay variability of the baseline value. ...

Compared with baseline values, UPC ratios decreased (P < .01) after 8 and 12 weeks at -20. However, all UPC ratios were within the

…
New Insights Into the Development of the Anterior Abdominal Wall.
Bouzada J, Gemmell C, Konschake M, Tubbs RS, Pechriggl E, Sañudo J. Bouzada J, et al. Front Surg. 2022 Mar 31;9:863679. doi: 10.3389/fsurg.2022.863679. eCollection 2022. Front Surg. 2022. PMID: 35433819 Free PMC article.
MATERIAL AND METHODS: In total, 19 human embryos corresponding to Carnegie stages 15-23, 36 fetuses with estimated gestational ages ranging from 9 weeks to term, and eight neonates were included in this study. All specimens belong to the collection of the Department of Ana …
MATERIAL AND METHODS: In total, 19 human embryos corresponding to Carnegie stages 15-23, 36 fetuses with estimated gestational ages ranging …
SARS-CoV CH.1.1 Variant: Genomic and Structural Insight.
Bazzani L, Imperia E, Scarpa F, Sanna D, Casu M, Borsetti A, Pascarella S, Petrosillo N, Cella E, Giovanetti M, Ciccozzi M. Bazzani L, et al. Infect Dis Rep. 2023 May 24;15(3):292-298. doi: 10.3390/idr15030029. Infect Dis Rep. 2023. PMID: 37367188 Free PMC article.
In early February 2023, the Omicron subvariant XBB.1.5, also known as "Kraken", accounted for more than 44% of new COVID-19 cases worldwide, whereas a relatively new Omicron subvariant named CH.1.1, deemed "Orthrus", accounted for less than 6% of new COVID-19 cases during the sub …
In early February 2023, the Omicron subvariant XBB.1.5, also known as "Kraken", accounted for more than 44% of new COVID-19 cases worldwide, …
[Treatment of radiation-induced iliofemoral arterial complications with groin radionecrosis].
Fichelle JM. Fichelle JM. J Med Vasc. 2017 Dec;42(6):358-366. doi: 10.1016/j.jdmv.2017.09.004. Epub 2017 Nov 1. J Med Vasc. 2017. PMID: 29203042 Review. French.
In one case, plastic coverage was done with an antebrachial flap (Chinese flap), which has been released at 6 weeks. One patient had post-radiotherapy iliofemoral vascular disease, but there was no vascular exposure, and no plastic coverage was necessary. ...
In one case, plastic coverage was done with an antebrachial flap (Chinese flap), which has been released at 6 weeks. One patient had …
106 results